Yuan Lu1, Shengfan Zhou2, Rachel P Dreyer1, Michael Caulfield3, Erica S Spatz1, Mary Geda4, Nancy P Lorenze4, Peter Herbert5, Gail D'Onofrio6, Elizabeth A Jackson7, Judith H Lichtman8, Héctor Bueno9, John A Spertus10, Harlan M Krumholz11. 1. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT; Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. 2. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT. 3. Quest Diagnostics Nichols Institute, San Juan Capistrano, CA. 4. Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. 5. Yale-New Haven Hospital, New Haven, CT. 6. Department of Emergency Medicine, Yale School of Medicine, New Haven, CT. 7. Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, MI. 8. Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT. 9. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Instituto de investigación i+12 and Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain. 10. University of Missouri-Kansas City and Saint Luke's Mid America Heart Institute, Kansas City, MO. 11. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT; Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT. Electronic address: harlan.krumholz@yale.edu.
Abstract
BACKGROUND: Young women with acute myocardial infarction (AMI) have higher mortality risk than similarly aged men. An adverse lipid profile is an important risk factor for cardiovascular outcomes after AMI, but little is known about whether young women with AMI have a higher-risk lipid pattern than men. We characterized sex differences in lipid profiles and treatment utilization among young adults with AMI. METHODS: A total of 2,219 adults with AMI (1,494 women) aged 18-55 years were enrolled from 103 hospitals in the United States (2008-2012). Serum lipids and lipoprotein subclasses were measured 1 month after discharge. RESULTS: More than 90% of adults were discharged on a statin, but less than half received a high-intensity dose and 12% stopped taking treatments by 1 month. For both men and women, the median of low-density lipoprotein (LDL) cholesterol was reduced to <100 mg/dL 1 month after discharge for AMI, but high-density lipoprotein (HDL) cholesterol remained <40 mg/dL. Multivariate regression analyses showed that young women had favorable lipoprotein profiles compared with men: women had higher HDL cholesterol and HDL large particle, but lower total cholesterol-to-HDL cholesterol ratio and LDL small particle. CONCLUSIONS: Young women with AMI had slightly favorable lipid and lipoprotein profiles compared with men, suggesting that difference in lipid and lipoprotein may not be a major contributor to sex differences in outcomes after AMI. In both men and women, statin remained inadequately used, and low HDL cholesterol level was a major lipid abnormality.
BACKGROUND: Young women with acute myocardial infarction (AMI) have higher mortality risk than similarly aged men. An adverse lipid profile is an important risk factor for cardiovascular outcomes after AMI, but little is known about whether young women with AMI have a higher-risk lipid pattern than men. We characterized sex differences in lipid profiles and treatment utilization among young adults with AMI. METHODS: A total of 2,219 adults with AMI (1,494 women) aged 18-55 years were enrolled from 103 hospitals in the United States (2008-2012). Serum lipids and lipoprotein subclasses were measured 1 month after discharge. RESULTS: More than 90% of adults were discharged on a statin, but less than half received a high-intensity dose and 12% stopped taking treatments by 1 month. For both men and women, the median of low-density lipoprotein (LDL) cholesterol was reduced to <100 mg/dL 1 month after discharge for AMI, but high-density lipoprotein (HDL) cholesterol remained <40 mg/dL. Multivariate regression analyses showed that young women had favorable lipoprotein profiles compared with men: women had higher HDL cholesterol and HDL large particle, but lower total cholesterol-to-HDL cholesterol ratio and LDL small particle. CONCLUSIONS: Young women with AMI had slightly favorable lipid and lipoprotein profiles compared with men, suggesting that difference in lipid and lipoprotein may not be a major contributor to sex differences in outcomes after AMI. In both men and women, statin remained inadequately used, and low HDL cholesterol level was a major lipid abnormality.
Authors: Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert Journal: Circulation Date: 2006-05-16 Impact factor: 29.690
Authors: Rachel P Dreyer; Kim G Smolderen; Kelly M Strait; John F Beltrame; Judith H Lichtman; Nancy P Lorenze; Gail D'Onofrio; Héctor Bueno; Harlan M Krumholz; John A Spertus Journal: Eur Heart J Acute Cardiovasc Care Date: 2015-02-13
Authors: Chiara Melloni; Bimal R Shah; Fang-Shu Ou; Matthew T Roe; Sidney C Smith; Charles V Pollack; Magnus Ohman; W Brian Gibler; Eric D Peterson; Karen P Alexander Journal: Am Heart J Date: 2010-12 Impact factor: 4.749
Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245
Authors: Michelle M Yore; Sandra A Ham; Barbara E Ainsworth; Judy Kruger; Jared P Reis; Harold W Kohl; Caroline A Macera Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: Samia Mora; James D Otvos; Nader Rifai; Robert S Rosenson; Julie E Buring; Paul M Ridker Journal: Circulation Date: 2009-02-09 Impact factor: 29.690
Authors: Rachel P Dreyer; Christopher Sciria; Erica S Spatz; Basmah Safdar; Gail D'Onofrio; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2017-02-22
Authors: Sagar B Dugani; Yousif M Hydoub; Ana Patricia Ayala; Roger Reka; Tarek Nayfeh; Jingyi Francess Ding; Shannon N McCafferty; Muayad Alzuabi; Medhat Farwati; M Hassan Murad; Alawi A Alsheikh-Ali; Samia Mora Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-06-23
Authors: Xin Zheng; Rachel P Dreyer; Jeptha P Curtis; Shuling Liu; Xiao Xu; Xueke Bai; Xi Li; Haibo Zhang; Siming Wang; Frederick A Masoudi; John A Spertus; Jing Li; Harlan M Krumholz Journal: J Am Heart Assoc Date: 2020-03-05 Impact factor: 5.501
Authors: Sagar B Dugani; Ana Patricia Ayala Melendez; Roger Reka; Yousif M Hydoub; Shannon N McCafferty; M Hassan Murad; Alawi A Alsheikh-Ali; Samia Mora Journal: BMJ Open Date: 2019-02-11 Impact factor: 2.692